HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nanotechnology Benefits/Risks Presented To FDA Nanotech Task Force

This article was originally published in The Rose Sheet

Executive Summary

Governments, businesses and academia should take a balanced approach in developing a policy framework for nanotechnology to reap its economic and societal benefits, according to Matthew Jaffe of the Washington, D.C. law firm Crowell & Moring
Advertisement

Related Content

EC Committee Proposes New Nanomaterials Risk Assessment Procedure
EC Committee Proposes New Nanomaterials Risk Assessment Procedure
Public Opinion Will Affect The Course Of Nanotech Development, Experts Say
Public Opinion Will Affect The Course Of Nanotech Development, Experts Say
Acting Commissioner Von Eschenbach Made Permanent In Time For New Year
“Aging Interruption,” Global Expansion Will Grow Nu Skin In 2007 – Chang
2008 Budget Should Cover Research On Nanotech Risk – Congressmen
Nanotechnology Regulation Limited By FDA Budget Constraints – Report
Nanomaterial Sunscreens Should Be Designated “New Drugs” – Petition
Nanomaterial Sunscreens Should Be Designated “New Drugs” – Petition
Advertisement
UsernamePublicRestriction

Register

RS014286

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel